// App-Quantinova.ai

178 : A First in Human Multi-center, Open Label, Prospective Study to Evaluate Safety, Usability and Performance of the VisONE System for Heart Failure with a Reduced Left Ventricular Ejection Fraction

Researchers

Presenter

  • John G.F. Cleland

Principal Investigators

  • Robin Young

  • Ana Jorbenadze

  • Tamaz Shaburishvili

  • Vitaly Demyanchuk

  • Roman Buriak

  • Borys Todurov

  • Kostyantyn Rudenko

  • Michel Zuber

  • Simon F. Stmpfli

  • Felix C. Tanner

  • Paul Erne

  • Michael Mirro

  • Lee R. Goldberg

Medical Centers

  • Robertson Centre of Biostatistics, University of Glasgow, Glasgow, United Kingdom

  • Heart Institute, Ministry of Health of Ukraine, Kiev, Ukraine

  • Amosov National Institute of Cardiovascular Surgery, Kiev, Ukraine

  • Department of Neurology, University Hospital Zurich, Zurich, Switzerland

  • Univ. Svizzera Italiana, Lugano, Switzerland

  • Indiana University, Fort Wayne, Indiana

  • Penn Medicine Heart Failure and Cardiac Transplant Center, University of Pennsylvania, Philadelphia, PA

Locations

  • United Kingdom

  • Georgia

  • Ukraine

  • Switzerland

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Congestive heart failure

  • Arrhythmia

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Open Label

  • Multicenteric

  • Prospective

  • First-In-Human

Phase

  • NA

Study Id's

  • NCT03484780

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved